Journal article
Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin
Journal of Antimicrobial Chemotherapy, Vol.71(8), pp.2213-2217
2016
Abstract
Objectives: Increasing reports of genetic overlap between animal and human sources of Clostridium difficile necessitate an understanding of antimicrobial susceptibility and resistance in these populations. In this study, we sought to investigate the in vitro activities of 13 antimicrobials against a unique collection of clade 5 C. difficile isolates of Australian animal and human origin. Methods: The collection comprised 171 C. difficile strains of human (n = 91) and animal (n = 80) origin in Australia in the last decade. The collection encompassed seven different clade 5 PCR ribotypes (RTs; 033, 078, 126, 127, 237, 281 and 288), seven STs and three toxin gene profiles. MICs were determined by agar incorporation methodology. Results: All isolates were fully susceptible, with little variation between strain populations, to vancomycin, metronidazole, fidaxomicin, rifaximin, amoxicillin/clavulanate, meropenem and piperacillin/tazobactam. Resistance to one or more of tetracycline, moxifloxacin, clindamycin or erythromycin was seen in 26.9% (46 of 171) of isolates, predominantly RTs 126 and 078 of human origin. Fifty per cent of this group were MDR. Human and animal isolates belonging to RTs 033, 237, 281 and 288 presented very similar and generally susceptible phenotypic profiles. Conclusions: Similar pan-susceptible phenotypic profiles seen for a large proportion of human and animal isolates of RTs 033, 237, 281 and 288 support the hypothesis of a common source. Conversely, human strain populations of RTs 126 and 127 show high proportions of antimicrobial resistance and limited phenotypic overlap with their animal counterparts.
Details
- Title
- Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin
- Authors/Creators
- D.R. Knight (Author/Creator) - The University of Western AustraliaT.V. Riley (Author/Creator) - The University of Western Australia
- Publication Details
- Journal of Antimicrobial Chemotherapy, Vol.71(8), pp.2213-2217
- Publisher
- Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy
- Identifiers
- 991005542171007891
- Copyright
- © The Author 2016.
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
42 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.120 Inflammatory Bowel Diseases & Infections
- 1.120.1133 Clostridium Infections
- Web Of Science research areas
- Infectious Diseases
- Microbiology
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology